you are here:

Shasun Pharmaceuticals Ltd.

BSE Live

Nov 17, 16:00
428.85 0.00 (0.00%)
Volume
No Data Available
79,828
  • Prev. Close

    428.85

  • Open Price

    410.00

  • Bid Price (Qty.)

    428.85 (3881)

  • Offer Price (Qty.)

    431.00 (1)

Shasun Pharmaceuticals is not traded on BSE in the last 30 days

NSE Live

Nov 17, 15:57
428.55 0.00 (0.00%)
Volume
No Data Available
507,063
  • Prev. Close

    428.55

  • Open Price

    410.60

  • Bid Price (Qty.)

    428.55 (4656)

  • Offer Price (Qty.)

    0.00 (0)

Shasun Pharmaceuticals is not traded on NSE in the last 30 days

ANNOUNCEMENTS ON Shasun Pharma

  • Nov 18, 2015 11:03 Source: BSE

    Shasun Pharma - Updates

    With reference to the earlier letter dated November 17, 2015 regarding the fire accident in one of the manufacturing blocks of the Company''s Cuddalore API facility, Shasun Pharmaceuticals Ltd has now informed BSE that the Company have temporarily suspended the production, as directed by the Government authorities. The Company is working with the Government authorities to resume operations at the earliest.The Company confirms that there will be no material impact on the revenue of the group during the current financial year.

  • Nov 17, 2015 14:22 Source: NSE

    Shasun Pharmaceuticals Limited

    Shasun Pharmaceuticals Limited has informed the Exchange that there was a fire accident at New production block during trial & commissioning in Cuddalore API facility on November 16, 2015. Company regrets to inform the sad demise of one worker in the accident. One more injured employee has been admitted in the hospital for treatment. The Company has informed the government authorities about the same and investigating the root cause of the accident.The damage on account of fire is being assessed for which the company has adequate insurance cover. However there will not be any significant loss of revenue or production due to the above accident.

  • Nov 17, 2015 14:05 Source: BSE

    Shasun Pharma - Updates

    Shasun Pharmaceuticals Ltd has informed BSE that:"We would like to inform you that there was a fire accident at New production block during trial & commissioning in Cuddalore API facility around 11.30 p.m on 16th November, 2015. We regret to inform the sad demise of one worker in the accident. One more injured employee has been admitted in the hospital for treatment. The company has informed the government authorities about the same and investigating the root cause of the accident.The damage on account of fire is being assessed for which the company has adequate insurance cover. However there will not be any significant loss of revenue or production due to the above accident."

  • Nov 16, 2015 12:07 Source: NSE

    Shasun Pharmaceuticals Limited

    Shasun Pharmaceuticals Limited has informed the Exchange regarding a press release dated November 16, 2015 titled "Shasun Pharmaceuticals receives USFDA approval for Carisoprodol Tablets".

  • Nov 16, 2015 11:16 Source: BSE

    Shasun Pharma - Shasun Pharmaceuticals receives USFDA approval for Carisoprodol Tablets

    Shasun Pharmaceuticals Ltd has informed BSE regarding a Press Release dated November 16, 2015 titled "Shasun Pharmaceuticals receives USFDA approval for Carisoprodol Tablets".

  • Nov 06, 2015 17:48 Source: BSE

    Shasun Pharma - Record Date for Scheme of Amalgamation

    Strides Arcolab Ltd has informed BSE that as approved by the Board of Directors of Strides Arcolab Ltd by a resolution passed on November 19, 2015 shall be the Record Date fixed for the purpose of determining the names of the shareholders of Shasun Pharmaceuticals Ltd who shall be entitled to shares in Strides Arcolab Ltd (as consideration under the Scheme of Amalgamation), in the exchange ratio of 5 (five) equity shares of Rs. 10/- each of Strides Arcolab Ltd for every 16 (sixteen) equity shares of Rs. 2/- each held in Shasun Pharmaceuticals Ltd.

  • Oct 27, 2015 14:25 Source: NSE

    Shasun Pharmaceuticals Limited

    Shasun Pharmaceuticals Limited has informed the Exchange regarding a press release dated October 27, 2015 titled "Shasun Pharmaceuticals Ltd announces strong Q2 FY 16 results".

  • Oct 27, 2015 14:12 Source: BSE

    Shasun Pharma - Financial Results with Results Press Release & Limited Review Report for Sept 30, 2015

    Shasun Pharmaceuticals Ltd has informed BSE about the Standalone Financial Results, Results Press Release & a copy of the Limited Review Report for the period ended September 30, 2015.

  • Oct 27, 2015 14:10 Source: NSE

    Shasun Pharmaceuticals Limited

    Shasun Pharmaceuticals Limited has submitted to the exchange the standalone & consolidated financial results along with the Limited Review Report for the period ended 30-Sep-2015.

  • Oct 19, 2015 16:05 Source: BSE

    Shasun Pharma - Board Intimation for Results & Closure of Trading Window

    Shasun Pharmaceuticals Ltd has informed BSE that a meeting of the Board of Directors of the Company is scheduled to the held on October 27, 2015, inter alia, to consider the Unaudited Financial Results for the quarter ended September 30, 2015.Further as per the provisions of the Company''s Code for Prevention of Insider Trading, the trading window for designated employees of the Company closed from September 10, 2015 to October 29, 2015 (both days inclusive).

BOARD MEETING

Meeting Date : Oct 27, 2015
Remark : Quarterly Results